Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trialAlbert M. Maguire, Jean Bennett, Gui‐Shuang Ying et al.|The Lancet|2009Cited by 857
Gene Therapy for Leber's Congenital Amaurosis is Safe and Effective Through 1.5 Years After Vector AdministrationFrancesca Simonelli, Alberto Auricchio, Albert M. Maguire et al.|Molecular Therapy|2009Cited by 551
Genotyping microarray (gene chip) for the<i>ABCR</i>(<i>ABCA4</i>) geneKaie Jaakson, Rando Allikmets, Jana Zernant et al.|Human Mutation|2003Cited by 238
Autosomal recessive familial exudative vitreoretinopathy: evidence for genetic heterogeneityGiuseppe de Crecchio, Pia Castelluccio, Francesca Simonelli et al.|Clinical Genetics|1998Cited by 68